One of the giants of the health insurance space, Anthem (NYSE:ANTM)
does a lot of things well. The company has leveraged its experience in
small group underwriting to become the most profitable public exchange
player and its acquisition of Amerigroup established a leading position
in Medicaid. Although Anthem remains a good commercial insurer, its weak
performance in Medicare Advantage (or MA) is a notable weakness and
likely a priority target for management over the next few years.
The ACA hasn't really hurt Anthem, nor other large players like UnitedHealth (NYSE:UNH), Aetna (NYSE:AET), and Humana (NYSE:HUM)
and I see little remaining risk there unless political and legal
maneuverings threaten to utterly overturn the system. The biggest
question I see for Anthem then is how they go about improving their MA
positioning - will this be a slow, mostly organic, multiyear process, or
will the company look to scoop up Humana? I don't see a lot of
undervaluation in these shares today unless it can grow behind a
mid-single digit rate, but I think it is a reasonably solid core holding
with upside to an improved MA position down the road.
Read the full article here:
With Medicaid And ACA Squared Away, Anthem Needs To Work On Medicare
No comments:
Post a Comment